These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurocysticercosis. An introduction with special emphasis on new developments in pharmacotherapy. Overbosch D Schweiz Med Wochenschr; 1992 Jun; 122(23):893-8. PubMed ID: 1615299 [TBL] [Abstract][Full Text] [Related]
4. Neurocysticercosis: a case report. Gasecki AP; Mawk JR; Hahn FJ; Wszolek ZK; McComb RD; Bennett DR Nebr Med J; 1989 Sep; 74(9):275-9. PubMed ID: 2674737 [No Abstract] [Full Text] [Related]
5. Profuse neurocysticercosis with minimal signs and a favorable outcome. Dumois JA; Whitman BW; Vezina LG Pediatr Infect Dis J; 1993 Oct; 12(10):885-7. PubMed ID: 8284131 [No Abstract] [Full Text] [Related]
6. Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. Proaño JV; Madrazo I; García L; García-Torres E; Correa D J Neurosurg; 1997 Jul; 87(1):29-33. PubMed ID: 9202261 [TBL] [Abstract][Full Text] [Related]
7. Drug treatment of neurocysticercosis. Garg RK Natl Med J India; 1997; 10(4):173-7. PubMed ID: 9325640 [TBL] [Abstract][Full Text] [Related]
8. [Cysticercosis of the brain in the USA]. Gasecki AP; Pfeiffer RF Neurol Neurochir Pol; 1990; 24(1-2):111-2. PubMed ID: 2132046 [No Abstract] [Full Text] [Related]
9. [Selective sensitivity of cysts to praziquantel and albendazole in a case of cerebral cysticercosis]. Cohen L; Belec L; Sanson M; Pierrot-Deseilligny C; Signoret JL Rev Neurol (Paris); 1992; 148(1):58-61. PubMed ID: 1604116 [TBL] [Abstract][Full Text] [Related]
10. Racemose neurocysticercosis after chronic meningitis: effect of medical treatment. La Mantia L; Costa A; Eoli M; Savoiardo M Clin Neurol Neurosurg; 1995 Feb; 97(1):50-4. PubMed ID: 7788974 [TBL] [Abstract][Full Text] [Related]
15. Neurocysticercosis. Suri W; Kalra V Med J Aust; 1994 Feb; 160(4):231-2. PubMed ID: 8309399 [No Abstract] [Full Text] [Related]
16. [Results of sequential prolonged courses of albendazole and praziquantel in recurrent neurocysticercosis]. Alla P; Carli P; Paris JF; Chagnon A Med Trop (Mars); 1996; 56(3):308. PubMed ID: 9026603 [No Abstract] [Full Text] [Related]
17. Clinical evaluation of albendazole and praziquantel in the treatment of cerebral cysticercosis. Cruz M; Cruz I; Horton J Southeast Asian J Trop Med Public Health; 1991 Dec; 22 Suppl():279-83. PubMed ID: 1822906 [TBL] [Abstract][Full Text] [Related]
18. Computed tomography and magnetic resonance imaging of neurocysticercosis. Palacios E; Salgado Lujambio P; Rojas Jasso R Semin Roentgenol; 1997 Oct; 32(4):325-34. PubMed ID: 9362100 [No Abstract] [Full Text] [Related]
20. [Tapeworms in the brain--a current problem in Norway?]. Dietrichs E; Tyssvang T; Aanonsen NO; Bakke SJ; Skullerud K Tidsskr Nor Laegeforen; 1994 Oct; 114(26):3089-92. PubMed ID: 7974432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]